fbpx

Discussing and Diagnosing These Difficult Infections


We want to welcome you to the first episode from our complicated UTI roundtable series, which is a collaborative effort that includes Contemporary Pediatrics, Contagion, and Contemporary OB/GYN. This series looks to discuss several topics around these infections including diagnosis, treatment, challenges in managing UTIs in patients with dementia and neurogenic bladders, antibiotic resistance, and considerations for patients and caregiver engagement.

Our panel of clinicians includes:

  • Barbara Trautner, MD, PhD, professor, Infectious Diseases, Section of Health Services Research, Baylor College of Medicine
  • Kimberly Claeys, PharmD, associate professor of Practice, Sciences, and Health Outcomes Research, University of Maryland Baltimore
  • Laila Woc-Colburn, MD, associate professor, Division of Infectious Diseases, Emory University School of Medicine

This 3-part series that will be posted every Wednesday over the coming weeks. In today’s episode, the clinicians discuss what constitutes a complicated UTI and how does diagnosis and treatment differ between patient groups, such as men versus women, pregnant patients, or pediatric patients.

This roundtable is part of ongoing educational and informational multimedia series we are producing and for any feedback or suggestions, please feel free to email John Parkinson at jparkinson@mjhlifesciences.com.



Source link

Daily Dose of Insights

Get a daily infusion of knowledge with our latest blog updates.

We don’t spam! Read our privacy policy for more info.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related articles

Mulled Cider | The Recipe Critic

This website may contain affiliate links and advertising so that we can provide recipes to you. Read...

A Monoclonal Antibodies’ Prospective Place in the COVID-19 PrEP Market

There is a marked difference in the COVID-19 vaccine effectiveness (VE) in the immunocompromised population. It is...

Baked Ricotta Dip | The Recipe Critic

This website may contain affiliate links and advertising so that we can provide recipes to you. Read...

Pfizer’s RSVpreF Vaccine Shows Efficacy in High-Risk Adults Aged 18-59

C3671023 Substudy A (NCT05842967)(MONeT Study) is a phase 3, randomized, double-blind, placebo-controlled trial assessing the safety and...